2006
DOI: 10.1016/j.brainres.2006.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Aldehyde load in ischemia–reperfusion brain injury: Neuroprotection by neutralization of reactive aldehydes with phenelzine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
80
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 81 publications
(81 citation statements)
references
References 46 publications
1
80
0
Order By: Relevance
“…In addition to H 2 O 2 , SMO produces 3-aminopropanal, a byproduct that contributes to the formation of acrolein, a highly reactive aldehyde. Acrolein associated with elevated polyamine catabolism has been strongly implicated in the etiology of diseases including ischemia-reperfusion injuries, renal failure, stroke, and silent brain infarction (39)(40)(41)(42)(43)(44). Further, elevated SMO expression has been observed in inflammation-associated human diseases including gastritis (22), ulcerative colitis (23), and prostatic intraepithelial neoplasia (24).…”
Section: Resultsmentioning
confidence: 99%
“…In addition to H 2 O 2 , SMO produces 3-aminopropanal, a byproduct that contributes to the formation of acrolein, a highly reactive aldehyde. Acrolein associated with elevated polyamine catabolism has been strongly implicated in the etiology of diseases including ischemia-reperfusion injuries, renal failure, stroke, and silent brain infarction (39)(40)(41)(42)(43)(44). Further, elevated SMO expression has been observed in inflammation-associated human diseases including gastritis (22), ulcerative colitis (23), and prostatic intraepithelial neoplasia (24).…”
Section: Resultsmentioning
confidence: 99%
“…10 While the molecular mechanisms of 4-HNE mitochondrial toxicity still remain unclear, it has been observed demonstrated that the generation of additional ROS and additional LP initiation is involved in the mechanism(s) of 4-HNE-induced neurotoxicity. 26,27 Whatever the intricacies of 4-HNE neurotoxicity are, the loss of mitochondrial integrity is the pivotal event leading to neuronal cell death in the ischemic penumbra in stroke models 13 and in models of acute neurological injury including TBI 1,28 and spinal cord injury. 29,30 Our in vitro data demonstrate protective effects of PZ against 4-HNE-induced bioenergetic function and oxidative damage in isolated mitochondria that tracks with a decrease in 4-HNE modification of mitochondrial proteins.…”
Section: Discussionmentioning
confidence: 99%
“…However, PZ has been shown by others to attenuate acrolein toxicity in cultured retinal ganglion cells by sequestration of acrolein. 13 This effect of PZ caused us to investigate whether PZ could similarly protect against early mitochondrial failure during the first 3 hours after TBI. As shown, a single subcutaneous dose of PZ at 15 minutes after TBI significantly reduced the degree of post-TBI S h a m V e h i c l e P h e n e l z i n e S h a m V e h i c l e P h e n e l z i n e S h a m V e h i c l e P h e n e l z i n e respiratory compromise, and this effect appears to be related to a decrease in 4-HNE modified mitochondrial proteins in the contusion and immediate peri-contusion area (the latter data not shown).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Seeking to offset such damage, researchers have explored the use of nucleophilic drugs to scavenge "free" carbonyls within cells, attempting to attenuate macromolecular adduction and any accompanying toxicity (Aldini et al, 2007(Aldini et al, , 2011aBurcham, 2008). Agents that have attracted attention as "carbonyl scavengers" include the neuroprotectant evaradone (Aldini et al, 2010), the antidepressant phenelzine (Wood et al, 2006), the hypoglycemic metformin (Ruggiero-Lopez et al, 1999), the antimicrobial isoniazid (Galvani et al, 2008), the dipeptide carnosine (Aldini et al, 2011b), the vasodilator hydralazine , the antioxidant ascorbate (Kesinger et al, 2010), and various biogenic polyphenolic compounds (Zhu et al, 2009). For some of these agents, interpreting their in vivo efficacy is complicated by "secondary" pharmacological actions unrelated to carbonyl-sequestering reactivity; hence, further medicinal chemistry workup may be needed to derive useful "pharmacologically inert" carbonyl scavengers Bouguerne et al, 2011).…”
Section: Introductionmentioning
confidence: 99%